Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
The Best Savings For Senior Citizens
Neil Wertheimer, deputy editor for the AARP Bulletin and The Magazine, talks about some of the highlights from this year's list of 99 Great Ways to Save.
Load More